logo
Select company
Select metric
-8096.85%EBIT Margin
VS
Market
2
Sector
7
Industry
12
History
12
$ 0.37Close
$ 0.29 - $ 4.28 52-Week Range
Ticker Information

Ticker

VYNE

Company Name

VYNE THERAPEUTICS INC

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

VYNE THERAPEUTICS INC - EBIT Margin Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

VYNE - EBIT % Historical data
DateEarning Before Interest & Taxes (EBIT)EBIT MarginRevenues
6/30/2025$ -38.54M-8096.85%$ 476K
3/31/2025$ -42.19M-6973.88%$ 605K
12/31/2024$ -39.83M-7950.1%$ 501K
9/30/2024$ -34M-6896.55%$ 493K
6/30/2024$ -28.43M-5849.18%$ 486K
3/31/2024$ -29.08M-6874.47%$ 423K
12/31/2023$ -28.45M-6710.38%$ 424K
9/30/2023$ -32.2M-9094.92%$ 354K
6/30/2023$ -35.07M-8616.95%$ 407K
3/31/2023$ -33.49M-8414.32%$ 398K
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • VYNE THERAPEUTICS INC's latest trailing twelve months (TTM) EBIT % stands at -1503.51%.
  • Over the past 5 years, VYNE THERAPEUTICS INC's average EBIT % has been -4365.75%.
  • The median EBIT % for VYNE THERAPEUTICS INC during this period was -5356.14%
  • VYNE THERAPEUTICS INC reached its highest EBIT % over the past 5 years at -406.96%.
  • The lowest EBIT % recorded by VYNE THERAPEUTICS INC in the same timeframe -9094.92%

VYNE THERAPEUTICS INC's EBIT % vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBIT % Benchmarks
CompanyEBIT %
ERNA : ERNEXA THERAPEUTICS INC -7890.57%BRTX : BIORESTORATIVE THERAPIES INC -1771.91%HCWB : HCW BIOLOGICS INC -6270.17%LYRA : LYRA THERAPEUTICS INC -5041.17%APRE : APREA THERAPEUTICS INC -1766.47%AIM : AIM IMMUNOTECH INC -12858.68%IBIO : IBIO INC -4541.25%ADIL : ADIAL PHARMACEUTICALS INC -CELZ : CREATIVE MEDICAL TECHNOLOGY HOLDINGS INC -96093.48%DWTX : DOGWOOD THERAPEUTICS INC -

Definition of EBIT Margin

[Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
EBIT / Revenues
(=) EBIT %
EBIT % for VYNE THERAPEUTICS INC is calculated as follows: EBIT [ $ -251.19M ] / Revenues [ $ 16.71M ]
(=) EBIT % [ -1503.51% ]

VYNE - EBIT Margin, Last 5 years

-9094.92%

Minimum

Sep 30, 2023

-406.96%

Maximum

Mar 31, 2022

-4365.75%

Average

-5356.14%

Median

EBIT % Benchmark Analysis

The chart above depicts the distribution of EBIT % for companies in the Total Stock Market. The average EBIT % of the companies is 9.55% with a standard deviation of 23.96%.
The following table provides additional summary stats:
EBIT % in the Market:
filtered constituents3.26K
min-73.16%
max83.08%
average9.55%
median9.01%
std23.96%